The CEO of BionTech says that it will work with other companies to increase the production capacity of vacancies

The CEO of BionTech says that it will work with other companies to increase the production capacity of vacancies

by
Vials of the Pfizer-BioNTech COVID-19 vaccine are seen before the vaccination of the first person in the German federal state of Brandenburg, at a care facility DRK-Seniorenwohnpark Grossraeschen, as the outbreak of coronavirus (COVID-19) in Grossraeschen continues . Germany, 27 December 2020. REUTERS / Fabrizio Bensch / Pool
Vials of the Pfizer-BioNTech COVID-19 vaccine are seen before the vaccination of the first person in the German federal state of Brandenburg, at a care facility DRK-Seniorenwohnpark Grossraeschen, as the outbreak of coronavirus (COVID-19) in Grossraeschen continues . Germany, 27 December 2020. REUTERS / Fabrizio Bensch / Pool

The executive director of BioNTech, Ugur Sahin, said that his company was able to cooperate with others, and that search to increase the production capacity of its COVID-19 vehicle developed with Pfizer, which indicates that it is stable considering opening a seat in Turkey.

I know that BioNTech aspiraba to distribute 1,300 million doses of its product for fines of 2021 and that 70% of the world needs to be evacuated before the next winter to return to the “normal life”, following an interview with the Turkish state agency Anadolu.

‘We will produce more than a thousand million doses with Pfizer next year. We need to distribute to more than 80 countries”, Dijo. ‘This is not easy. The vacancies are manufactured in a complete manner. We want to cooperate with other companies”.

“If we can concretize our plans on how to increase capacity, we can divulge them in February or February. Creo que podemos aumentarla. We do not have a guaranteed plan ”.

Ugur Sahin found BionTech next to him (Reuters)
Ugur Sahin found BionTech next to him (Reuters)

Ankara agreed to buy 4.5 million doses of the BioNTech and Pfizer vaccine, with the option to purchase 30 million more doses. Sahin, hijo de un immigrant turco in Alemania, dijo a Anadolu that BioNTech is in talks with the Turkish state-owned agency Tubitak, and that its goal was to add 30 million doses to countries for fines of 2021. “It is a great power to help people in Turkey”, the executive said , según lo citó Anadolu.

‘We would also like to carry out investigations in Turkey. We have conversations with Tubitak, we started working with some professors at universities. We want to open a subsidiary of the BioNTech company in Turkey”, Añadió.

A total of 16 countries and the European Union (composed of 27 States) validate the Pfizer / BioNTech munitions.

Thus, the other 16 vacancies are in the final phase of development, following the latest dates of the World Health Organization (WHO), which include those that are currently being summarized.

Information about the FDA regarding the Pfizer / BioNTech vaccine, which can provoke dollars in the zone in which the injection is carried out in the brazier (in 80% of cases), as well as other effects on diseases, for example, punishment, of cabeza and musculares, and fever of more exceptional manner.

Experts from the EU consider that the current vacancies are already effective in the new year of covid-19 discovered in the United Kingdom, which, according to British scientific authorities, is between 50% and 74% more contagious.

“At the moment, there is no evidence to suggest” that the Pfizer / BioNTech vaccine “does not affect the new cepa”, indicates the European Medicines Agency.

(Reuters information on AFP)

MORE ABOUT THIS THEME:

Coronavirus effect: targets the most deadly cities in 2020

The Director-General of the OMS warns of future pandemics

Source